These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 19020970)

  • 1. Adherence to antiretroviral therapy among HIV-infected drug users: a meta-analysis.
    Malta M; Magnanini MM; Strathdee SA; Bastos FI
    AIDS Behav; 2010 Aug; 14(4):731-47. PubMed ID: 19020970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: a systematic review.
    Malta M; Strathdee SA; Magnanini MM; Bastos FI
    Addiction; 2008 Aug; 103(8):1242-57. PubMed ID: 18855813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence and plasma HIV RNA response to antiretroviral therapy among HIV-seropositive injection drug users in a Canadian setting.
    Nolan S; Milloy MJ; Zhang R; Kerr T; Hogg RS; Montaner JS; Wood E
    AIDS Care; 2011 Aug; 23(8):980-7. PubMed ID: 21480010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alcohol Use and Antiretroviral Therapy Non-Adherence Among Adults Living with HIV/AIDS in Sub-Saharan Africa: A Systematic Review and Meta-Analysis.
    Velloza J; Kemp CG; Aunon FM; Ramaiya MK; Creegan E; Simoni JM
    AIDS Behav; 2020 Jun; 24(6):1727-1742. PubMed ID: 31673913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
    Aziz N; Sokoloff A; Kornak J; Leva NV; Mendiola ML; Levison J; Feakins C; Shannon M; Cohan D
    BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of injecting drug use on response to highly active antiretroviral treatment in HIV-1-infected patients: a nationwide population-based cohort study.
    Larsen MV; Omland LH; Gerstoft J; Røge BT; Larsen CS; Pedersen G; Obel N; Kronborg G
    Scand J Infect Dis; 2010 Dec; 42(11-12):917-23. PubMed ID: 20840000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly active antiretroviral therapy (HAART) among HIV-infected drug users: a prospective cohort study of sexual risk and injecting behaviour.
    Smit C; Lindenburg K; Geskus RB; Brinkman K; Coutinho RA; Prins M
    Addiction; 2006 Mar; 101(3):433-40. PubMed ID: 16499516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to highly active antiretroviral therapy (HAART): a meta-analysis.
    Ortego C; Huedo-Medina TB; Llorca J; Sevilla L; Santos P; Rodríguez E; Warren MR; Vejo J
    AIDS Behav; 2011 Oct; 15(7):1381-96. PubMed ID: 21468660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "We fear the police, and the police fear us": structural and individual barriers and facilitators to HIV medication adherence among injection drug users in Kiev, Ukraine.
    Mimiaga MJ; Safren SA; Dvoryak S; Reisner SL; Needle R; Woody G
    AIDS Care; 2010 Nov; 22(11):1305-13. PubMed ID: 20640954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of prior antiretroviral experience on adherence and responses to new highly active antiretroviral therapy regimens.
    Horberg M; Silverberg M; Hurley L; Delorenze G; Quesenberry C
    AIDS Patient Care STDS; 2008 Apr; 22(4):301-12. PubMed ID: 18338961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication persistence of HIV-infected drug users on directly administered antiretroviral therapy.
    Ing EC; Bae JW; Maru DS; Altice FL
    AIDS Behav; 2013 Jan; 17(1):113-21. PubMed ID: 22105340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of an adherence program to antiretroviral treatment on virologic response in a cohort of multitreated and poorly adherent HIV-infected patients in Spain.
    Navarro J; Pérez M; Curran A; Burgos J; Feijoo M; Torrella A; Caballero E; Ocaña I; Ribera E; Crespo M; Falcó V
    AIDS Patient Care STDS; 2014 Oct; 28(10):537-42. PubMed ID: 25111167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Level of adherence and HIV RNA suppression in the current era of highly active antiretroviral therapy (HAART).
    Viswanathan S; Detels R; Mehta SH; Macatangay BJ; Kirk GD; Jacobson LP
    AIDS Behav; 2015 Apr; 19(4):601-11. PubMed ID: 25342151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into reasons for discontinuation according to year of starting first regimen of highly active antiretroviral therapy in a cohort of antiretroviral-naïve patients.
    Cicconi P; Cozzi-Lepri A; Castagna A; Trecarichi EM; Antinori A; Gatti F; Cassola G; Sighinolfi L; Castelli P; d'Arminio Monforte A;
    HIV Med; 2010 Feb; 11(2):104-13. PubMed ID: 19732176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex differences in adherence to highly active antiretroviral therapy: a meta-analysis.
    Ortego C; Huedo-Medina TB; Santos P; Rodríguez E; Sevilla L; Warren M; Llorca J
    AIDS Care; 2012; 24(12):1519-34. PubMed ID: 22533692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
    Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
    Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What do HIV-positive drug users' experiences tell us about their antiretroviral medication-taking? An international integrated literature review.
    Ho IS; Holloway A; Stenhouse R
    Addiction; 2020 Apr; 115(4):623-652. PubMed ID: 31626354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How does hard-to-reach status affect antiretroviral therapy adherence in the HIV-infected population? Results from a meta-analysis of observational studies.
    Lin D; Zhang CY; He ZK; Zhao XD
    BMC Public Health; 2019 Jun; 19(1):789. PubMed ID: 31221113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Harm reduction intensity-Its role in HAART adherence amongst drug users in Amsterdam.
    Lambers FA; Stolte IG; van den Berg CH; Coutinho RA; Prins M
    Int J Drug Policy; 2011 May; 22(3):210-8. PubMed ID: 21392958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.